Two Clinical Studies of an Experimental Drug for Duchenne Muscular Dystrophy Have Been Stopped
DarkoStojanovic / Pixabay

Two Clinical Studies of an Experimental Drug for Duchenne Muscular Dystrophy Have Been Stopped

According to a recent press release, Pfizer Inc. has terminated two on-going clinical trials that were investigating domagrozumab (PF-06252616) as a potential treatment for Duchenne muscular dystrophy. This decision follows…

Continue Reading Two Clinical Studies of an Experimental Drug for Duchenne Muscular Dystrophy Have Been Stopped

A Study of an Investigational Acute Myeloid Leukaemia and Myelodysplastic Syndrome Drug Has Completed Enrolment

  The company Imago Biosciences, which focuses on developing anti-cancer therapies, is carrying out a Phase 1/2a clinical study of an investigational drug called IMG-7289 as a potential treatment for…

Continue Reading A Study of an Investigational Acute Myeloid Leukaemia and Myelodysplastic Syndrome Drug Has Completed Enrolment

Women on Medicare Aren’t Getting Genetic Tests for Breast and Ovarian Cancer

According to a story from medicinenet.com, a recent study found that women on Medicare are not getting genetic tests for BRCA mutations that could lead to ovarian cancer and breast…

Continue Reading Women on Medicare Aren’t Getting Genetic Tests for Breast and Ovarian Cancer
Close Menu